Alone Group:CPT

4 trials

Sponsors

CCMU Beijing Chaoyang Hostipital, 307th Hospital of People's Liberation Army, Fudan University Shanghai Cancer Center

Conditions

Relapsed or Refractory Multiple Myelomaadvanced gastric cancer and colorectal cancerlung cancer, colon cancer, lymphoma, multiple myeloma, etc.

Phase 1

Phase Ib dose-finding and pharmacokinetics study of CPT injection in MM

Active, not recruitingChiCTR-TNRC-12001896

CCMU Beijing Chaoyang HostipitalRelapsed or Refractory Multiple Myeloma

Start: 2008-11-20Updated: 2017-04-18

Phase Ia clinical trial of CPT injection

Active, not recruitingChiCTR-ONRC-12002084

307th Hospital of People's Liberation Armylung cancer, colon cancer, lymphoma, multiple myeloma, etc.

Start: 2005-04-01Updated: 2017-04-18

Phase 2

Multi-center, open-label phase II trial of CPT in MM: stage I

Active, not recruitingChiCTR-ONC-12002065

CCMU Beijing Chaoyang HostipitalRelapsed or Refractory Multiple Myeloma

Start: 2007-09-01Updated: 2017-04-18

Exploratory phase IIa study of CPT in the treatment of multiple malignant solid tumors

Active, not recruitingChiCTR-ONRC-12002086

Fudan University Shanghai Cancer Centeradvanced gastric cancer and colorectal cancer

Start: 2009-12-28Updated: 2017-04-18

Related Papers

Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma.

2016-09-0821 citations